View in EDS HTML Full Text PDF Full Text

Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL.

Saved in:
Bibliographic Details
Title: Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL.
Authors: Wenzl K; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Stokes ME; Informatics and Predictive Sciences, , Bristol Myers Squibb, Summit, NJ, USA., Novak JP; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Bock AM; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Khan S; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hopper MA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Krull JE; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Dropik AR; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Walker JS; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Sarangi V; Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Mwangi R; Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Ortiz M; Informatics and Predictive Sciences, Celgene Institute for Translational Research Europe (CITRE), Seville, Spain., Stong N; Informatics and Predictive Sciences, , Bristol Myers Squibb, Summit, NJ, USA., Huang CC; Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ, USA., Maurer MJ; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Rimsza L; Division of Hematopathology, Mayo Clinic, Scottsdale, AZ, USA., Link BK; Division of Hematology, University of Iowa, Iowa, USA., Slager SL; Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Asmann Y; Department of Quantitative Health Sciences Research, Mayo Clinic, Jacksonville, FL, USA., Mondello P; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Morin R; Genome Sciences Center, British Columbia Cancer Agency, Vancouver, BC, Canada., Ansell SM; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Habermann TM; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Witzig TE; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Feldman AL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., King RL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Nowakowski G; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Cerhan JR; Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Gandhi AK; Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ, USA., Novak AJ; Division of Hematology, Mayo Clinic, Rochester, MN, USA. Novak.Anne@mayo.edu.
Source: Blood cancer journal [Blood Cancer J] 2024 Jun 20; Vol. 14 (1), pp. 100. Date of Electronic Publication: 2024 Jun 20.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38902256
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wenzl+K%22">Wenzl K</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Stokes+ME%22">Stokes ME</searchLink>; Informatics and Predictive Sciences, , Bristol Myers Squibb, Summit, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Novak+JP%22">Novak JP</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Bock+AM%22">Bock AM</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Khan+S%22">Khan S</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Hopper+MA%22">Hopper MA</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Krull+JE%22">Krull JE</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Dropik+AR%22">Dropik AR</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Walker+JS%22">Walker JS</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Sarangi+V%22">Sarangi V</searchLink>; Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Mwangi+R%22">Mwangi R</searchLink>; Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Ortiz+M%22">Ortiz M</searchLink>; Informatics and Predictive Sciences, Celgene Institute for Translational Research Europe (CITRE), Seville, Spain.<br /><searchLink fieldCode="AU" term="%22Stong+N%22">Stong N</searchLink>; Informatics and Predictive Sciences, , Bristol Myers Squibb, Summit, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Huang+CC%22">Huang CC</searchLink>; Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Maurer+MJ%22">Maurer MJ</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Rimsza+L%22">Rimsza L</searchLink>; Division of Hematopathology, Mayo Clinic, Scottsdale, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Link+BK%22">Link BK</searchLink>; Division of Hematology, University of Iowa, Iowa, USA.<br /><searchLink fieldCode="AU" term="%22Slager+SL%22">Slager SL</searchLink>; Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Asmann+Y%22">Asmann Y</searchLink>; Department of Quantitative Health Sciences Research, Mayo Clinic, Jacksonville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Mondello+P%22">Mondello P</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Morin+R%22">Morin R</searchLink>; Genome Sciences Center, British Columbia Cancer Agency, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Ansell+SM%22">Ansell SM</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Habermann+TM%22">Habermann TM</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Witzig+TE%22">Witzig TE</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Feldman+AL%22">Feldman AL</searchLink>; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22King+RL%22">King RL</searchLink>; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Nowakowski+G%22">Nowakowski G</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Cerhan+JR%22">Cerhan JR</searchLink>; Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Gandhi+AK%22">Gandhi AK</searchLink>; Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Novak+AJ%22">Novak AJ</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA. Novak.Anne@mayo.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2024 Jun 20; Vol. 14 (1), pp. 100. <i>Date of Electronic Publication: </i>2024 Jun 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38902256
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-024-01080-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100
    Titles:
      – TitleFull: Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wenzl K
      – PersonEntity:
          Name:
            NameFull: Stokes ME
      – PersonEntity:
          Name:
            NameFull: Novak JP
      – PersonEntity:
          Name:
            NameFull: Bock AM
      – PersonEntity:
          Name:
            NameFull: Khan S
      – PersonEntity:
          Name:
            NameFull: Hopper MA
      – PersonEntity:
          Name:
            NameFull: Krull JE
      – PersonEntity:
          Name:
            NameFull: Dropik AR
      – PersonEntity:
          Name:
            NameFull: Walker JS
      – PersonEntity:
          Name:
            NameFull: Sarangi V
      – PersonEntity:
          Name:
            NameFull: Mwangi R
      – PersonEntity:
          Name:
            NameFull: Ortiz M
      – PersonEntity:
          Name:
            NameFull: Stong N
      – PersonEntity:
          Name:
            NameFull: Huang CC
      – PersonEntity:
          Name:
            NameFull: Maurer MJ
      – PersonEntity:
          Name:
            NameFull: Rimsza L
      – PersonEntity:
          Name:
            NameFull: Link BK
      – PersonEntity:
          Name:
            NameFull: Slager SL
      – PersonEntity:
          Name:
            NameFull: Asmann Y
      – PersonEntity:
          Name:
            NameFull: Mondello P
      – PersonEntity:
          Name:
            NameFull: Morin R
      – PersonEntity:
          Name:
            NameFull: Ansell SM
      – PersonEntity:
          Name:
            NameFull: Habermann TM
      – PersonEntity:
          Name:
            NameFull: Witzig TE
      – PersonEntity:
          Name:
            NameFull: Feldman AL
      – PersonEntity:
          Name:
            NameFull: King RL
      – PersonEntity:
          Name:
            NameFull: Nowakowski G
      – PersonEntity:
          Name:
            NameFull: Cerhan JR
      – PersonEntity:
          Name:
            NameFull: Gandhi AK
      – PersonEntity:
          Name:
            NameFull: Novak AJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 06
              Text: 2024 Jun 20
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1